THE CURRENT LANDSCAPE Intravenous (IV) Busulfan is an alkylating drug routinely used in conditioning regimens before allogenic haemopoietic cell transplantation (HCT), the standard treatment for various malignant and non-malignant disorders. However, drug exposure must be maintained within a narrow therapeutic range. If the drug exposure is too high, there is...
Read more
DoseMe as the world’s first company to design a precision dosing platform for clinical use - DoseMeRx - will attend and exhibit at the American Society of Health System Pharmacists Midyear Clinical Meeting from December 2-6 in Anaheim, California. DoseMeRx allows healthcare professionals to dose a patient based on their...
Read more
This month, the American Journal of Health System Pharmacists published ‘Making the change to area under the curve-based vancomycin dosing’ (Heil EL et al. AJHP. 2018) providing practical advice for implementing an AUC-based vancomycin dosing strategy for adult patients. The paper highlights population pharmacokinetic modelling with the use of...
Read more
THE CUSTOMER Maribor University Medical Centre is one of the largest medical institutions in Slovenia. It is a public health care institution performing healthcare services on secondary and tertiary level for the wider region of Maribor, Pesnica, Ruše, Ormož, Lenart, Ptuj and Slovenska Bistrica. THE CHALLENGE Despite the emergence of new drugs,...
Read moreHIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.
